Belfast · Northern Ireland
TheBELFAST HERALDLocal knowledge. National perspective.
Retrospective archiveHistorical reports were compiled from linked contemporaneous sources. Dates refer to the events covered.How the archive works
HealthPremium archive

Medicines and Healthcare products Regulatory Agency approves the country's first monoclonal antibody cocktail drug (Ronapreve) developed by Regeneron and Roche to treat…

The Medicines and Healthcare products Regulatory Agency approves the country's first monoclonal antibody cocktail drug (Ronapreve) developed by Regeneron and Roche to treat severe COVID-19 patients in the United Kingdom.

By Belfast Herald Newsdesk1 min read

Herald Premium Archive

This report is for subscribers

Sign in or choose a plan to read this report and the complete Premium retrospective archive.

HealthMedicines and Healthcare products Regulatory Agency approves the country's first monoclonal antibody cocktail drug (Ronapreve) developed by Regeneron and Roche to treat…

The Medicines and Healthcare products Regulatory Agency approves the country's first monoclonal antibody cocktail drug (Ronapreve) developed by Regeneron and Roche to treat severe COVID-19 patients in the United Kingdom.

View Premium plansBrowse free archive reports